SCHEMBL3655006

SCHEMBL3655006

COCNC(=O)Oc1cc(Cl)ncn1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
TSHR P16473 1/20 0.33
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
FGFR4 P22455 1/20 0.31
BCHE P06276 1/20 0.31
LIPE Q05469 1/20 0.31
KMO O15229 1/20 0.31
MAP2K7 O14733 1/20 0.30
P2RX3 P56373 2/20 0.30
EGFR P00533 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1936666 0.78 ALDH1A1 (0.39) ALDH1A1L3MBTL1HPGDLMNAKDM4E
SCHEMBL1934857 0.78 L3MBTL1 (0.37) ALDH1A1L3MBTL1HPGDLMNAKDM4E
SCHEMBL6521518 0.78 MMP13 (0.42) ALDH1A1TSHRHPGDKDM4EGAA
SCHEMBL7769409 0.78 L3MBTL1 (0.48) ALDH1A1L3MBTL1HPGDGAA
SCHEMBL7767858 0.76 PTK2 (0.40) L3MBTL1TSHRKDM4EBCHELIPE
SCHEMBL27820544 0.74 KDM4E (0.38) ALDH1A1L3MBTL1TSHRHPGDLMNA
SCHEMBL1742128 0.72 KMO (0.35) KMO
SCHEMBL3660791 0.72 KMO (0.38) KMO
SCHEMBL2918657 0.71 JAK2 (0.39) ALDH1A1TSHRKDR
SCHEMBL11697983 0.71 ALOX15 (0.38) ALDH1A1LMNAKDM4EGAAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205590-B1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2014-06-04 EP disclosed
EP-2205590-A1 CGRP ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2010-07-14 EP disclosed
WO-2009050235-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed
WO-2009050232-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed